<div id="readability-page-1"><p>Brown Capital Management LLC lessened its holdings in  OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 6.8% during the second quarter, according to its most recent 13F filing with the Securities &amp; Exchange Commission. The fund owned 1,556,704 shares of the company's stock after selling 113,821 shares during the period. Brown Capital Management LLC owned approximately 6.21% of OrthoPediatrics worth $33,438,000 at the end of the most recent reporting period.</p><div><p><span></span><span>Get <strong>OrthoPediatrics</strong> alerts:</span></p></div><p>Several other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. increased its position in shares of  OrthoPediatrics by 1.5% during the first quarter. Vanguard Group Inc. now owns 937,969 shares of the company's stock valued at $23,102,000 after acquiring an additional 14,079 shares during the last quarter.  Millennium Management LLC increased its position in shares of  OrthoPediatrics by 55.3% during the 1st quarter. Millennium Management LLC now owns 656,578 shares of the company's stock valued at $16,172,000 after purchasing an additional 233,873 shares during the last quarter.  AWM Investment Company Inc. increased its position in shares of  OrthoPediatrics by 5.5% during the 1st quarter. AWM Investment Company Inc. now owns 545,282 shares of the company's stock valued at $13,430,000 after purchasing an additional 28,488 shares during the last quarter.  Harbor Capital Advisors Inc. raised its stake in shares of  OrthoPediatrics by 116.5% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 333,959 shares of the company's stock worth $7,173,000 after purchasing an additional 179,733 shares during the period.  Finally, Goldman Sachs Group Inc. boosted its holdings in shares of  OrthoPediatrics by 112.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company's stock worth $4,937,000 after buying an additional 106,041 shares during the last quarter. 69.05% of the stock is owned by institutional investors. </p><h2>OrthoPediatrics Price Performance</h2><p>Shares of NASDAQ KIDS opened at $18.17 on Friday. OrthoPediatrics Corp. has a twelve month low of $15.28 and a twelve month high of $27.60. The company has a quick ratio of 3.52, a current ratio of 7.40 and a debt-to-equity ratio of 0.28. The stock's 50-day simple moving average is $17.48 and its two-hundred day simple moving average is $19.69. The firm has a market capitalization of $455.70 million, a P/E ratio of -9.32 and a beta of 1.06. </p><p>OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its quarterly earnings data on Monday, January 9th. The company reported ($0.15) earnings per share for the quarter. OrthoPediatrics had a negative return on equity of 6.86% and a negative net margin of 20.06%.The business had revenue of $25.08 million during the quarter.  As a group, equities analysts anticipate that  OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year. </p><h2>Analysts Set New Price Targets</h2><p>Several brokerages have commented on KIDS. Weiss Ratings  reaffirmed a &#34;sell (e+)&#34; rating on shares of OrthoPediatrics in a research report on Wednesday, October 8th. Piper Sandler decreased their price target on shares of OrthoPediatrics from $30.00 to $22.00 and set an &#34;overweight&#34; rating for the company in a research note on Friday, October 10th. BTIG Research  reiterated a &#34;buy&#34; rating and issued a $23.00 price objective on shares of OrthoPediatrics in a research note on Wednesday, October 29th. Lake Street Capital reduced their price objective on OrthoPediatrics from $37.00 to $34.00 and set a &#34;buy&#34; rating for the company in a report on Friday, October 10th. Finally, Truist Financial  set a $18.00 target price on OrthoPediatrics in a research note on Friday, October 10th. Seven equities research analysts have rated the stock with a Buy rating, one  has issued  a Hold rating and one  has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $24.00.</p><p><b>Check Out Our Latest Stock Report on OrthoPediatrics</b></p><h2>About OrthoPediatrics</h2> (Free Report)<p>OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.</p><h2>See Also</h2><ul><li>Five stocks we like better than OrthoPediatrics</li><li>Transportation Stocks Investing</li><li>The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy</li><li>What is the Hang Seng index?  </li><li>Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF</li><li>Where Do I Find 52-Week Highs and Lows?</li><li>Strong Quarter, Weak Reaction: Why GitLab Shares Dropped</li></ul><p><strong>Want to see what other hedge funds are holding KIDS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9S0lEUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9S0lEUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in OrthoPediatrics Right Now?</h2><p>Before you consider OrthoPediatrics, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OrthoPediatrics wasn't on the list.</p><p>While OrthoPediatrics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

KIDS

<p>Brown Capital Management LLC reduced its stake in OrthoPediatrics Corp. by 6.8% in Q2, now holding 1,556,704 shares valued at $33,438,000. Other institutional investors have also adjusted their positions in the company. OrthoPediatrics' stock opened at $18.17, with a market cap of $455.70 million. Analysts have mixed ratings, with a consensus target price of $24.00. The company specializes in pediatric orthopedic devices.</p>

Brown Capital Management LLC Decreases Stake in OrthoPediatrics Corp. $KIDS